All Stories

  1. Blood pressure measurement in special populations and circumstances
  2. A randomized trial of the efficacy and safety of azilsartan medoxomil combined with chlorthalidone
  3. Cardiovascular Safety of the β3 -Adrenoceptor Agonist Mirabegron and the Antimuscarinic Agent Solifenacin in the SYNERGY Trial
  4. Nocturnal hypertension in diabetes: Potential target of sodium/glucose cotransporter 2 (SGLT2) inhibition
  5. Comparative effectiveness of an angiotensin receptor blocker, olmesartan medoxomil, in older hypertensive patients
  6. Prior Medications and the Cardiovascular Benefits From Combination Angiotensin‐Converting Enzyme Inhibition Plus Calcium Channel Blockade Among High‐Risk Hypertensive Patients
  7. Olmesartan-based monotherapy vs combination therapy in hypertension: A meta-analysis based on age and chronic kidney disease status
  8. Blood pressure variability and cardiovascular prognosis: implications for clinical practice
  9. Evaluation of the angiotensin II receptor blocker azilsartan medoxomil in African-American patients with hypertension
  10. Contributions to Hypertension Public Policy and Clinical Practice: A Review of Recent Reports
  11. Cardiovascular Outcomes According to Systolic Blood Pressure in Patients With and Without Diabetes: An ACCOMPLISH Substudy
  12. Ambulatory Blood Pressure Monitoring: New Directions and Uncertainties Arise From the U.S. Preventive Services Task Force Recommendation on the Diagnosis of Hypertension
  13. Renal Denervation for the Treatment of Hypertension: Making a New Start, Getting It Right
  14. A Tribute to Dr John H. Laragh
  15. Renal denervation for the treatment of hypertension: Making a new start, getting it right
  16. Renal Denervation for the Treatment of Hypertension: Making a New Start, Getting It Right
  17. Remembering Dr Marvin Moser
  18. The Evolving Clinical Management of Hypertension
  19. Response to “Opportunistic Screening for Atrial Fibrillation During Follow-Up of Treated Hypertension”
  20. The Journal of Clinical HypertensionHas Become the Official Journal of the World Hypertension League
  21. Recently Published Hypertension Guidelines of the JNC 8 Panelists, the American Society of Hypertension/International Society of Hypertension and Other Major Organizations: Introduction to a Focus Issue ofThe Journal of Clinical Hypertension
  22. Clinical Practice Guidelines for the Management of Hypertension in the Community
  23. ANTIHYPERTENSIVE EFFICACY OF THE NOVEL ANGIOTENSIN RECEPTOR BLOCKER AZILSARTAN MEDOXOMIL IN COMBINATION WITH AMLODIPINE: PP.16.99